Related Experiment Video
Updated: Aug 8, 2026
In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
DNA alterations in human oral squamous cell carcinomas detected by restriction landmark genomic scanning
K Yamamoto1, N Konishi, T Inui
1Second Department of Pathology, Nara Medical University, Japan.
Abstract:
Genetic abnormalities in human oral squamous cell carcinomas (OSCC) were examined using restriction landmark genomic scanning (RLGS), a method of two-dimensional gel analysis allowing detection of amplifications and other aberrations in genomic DNA. DNAs from 11 oral tumours as well as from contiguous normal squamous epithelium, were cleaved with the restriction enzyme Not I, [32p] end-labeled and electrophoretically size-fractionated. Following a second digestion employing Hinf I, the further fragmented DNA was again electrophoretically separated. Five fragments/spots were found amplified in at least 64% (7/11) (chromosome nos. 4, 9-12 or 22) of carcinomas, with one of these spots amplified in 100% (chromosome no. 4) of tumour samples. In addition, six other spots were frequently reduced in at least 55% (chromosome nos. 15 or 9-12) of tumour tissues. Further characterization of these common changes is needed to determine if they represent important alterations in OSCC.
Insights
Researchers identified genetic abnormalities in oral squamous cell carcinomas (OSCC) using restriction landmark genomic scanning (RLGS). Key DNA amplifications and reductions were found in most tumors, particularly on chromosome 4.
Area of Science:
- Genomics
- Cancer Biology
- Molecular Oncology
Background:
- Oral squamous cell carcinoma (OSCC) is a significant global health concern.
- Understanding the genetic landscape of OSCC is crucial for developing targeted therapies.
- Genomic instability is a hallmark of many cancers, including OSCC.
Purpose of the Study:
- To identify and characterize genetic aberrations in human oral squamous cell carcinomas (OSCC).
- To detect DNA amplifications and reductions in OSCC using a high-resolution genomic scanning technique.
Main Methods:
- Restriction landmark genomic scanning (RLGS), a 2D gel electrophoresis method, was employed.
- DNA from 11 OSCC tumors and adjacent normal tissue was analyzed.
- Genomic DNA was digested with Not I and Hinf I restriction enzymes and labeled with [32P].
Main Results:
- Five DNA fragments were amplified in at least 64% of OSCC samples, with one amplified in 100% (chromosome 4).
- Six DNA fragments showed frequent reductions (≥55%) in tumor tissues (chromosomes 15, 9-12).
- Consistent genomic alterations were observed across multiple OSCC samples.
Conclusions:
- Specific chromosomal regions (4, 9-12, 15, 22) harbor frequent genetic alterations in OSCC.
- The identified amplifications and reductions may represent critical events in OSCC development.
- Further investigation is warranted to validate these findings and their clinical significance in OSCC.
